Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 15, 2018

SELL
$64.88 - $75.68 $1.46 Million - $1.71 Million
-22,550 Closed
0 $0
Q1 2018

Apr 26, 2018

BUY
$72.84 - $88.8 $144,004 - $175,557
1,977 Added 9.61%
22,550 $1.7 Million
Q3 2017

Nov 06, 2017

BUY
$72.11 - $85.47 $1.48 Million - $1.76 Million
20,573
20,573 $1.56 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Lingohr & Partner Asset Management Gmb H Portfolio

Follow Lingohr & Partner Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lingohr & Partner Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Lingohr & Partner Asset Management Gmb H with notifications on news.